Digenio AG - Search Results

1

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.

Digenio AG, Mancuso JP, Gerber RA, Dvorak RV. Digenio AG, et al. Ann Intern Med. 2009 Feb 17;150(4):255-62. doi: 10.7326/0003-4819-150-4-200902170-00006. Ann Intern Med. 2009. PMID: 19221377 Clinical Trial.

2

Prandial insulin versus glucagon-like peptide-1 added to basal insulin: comparative effectiveness in the community practice setting.

Digenio A, Karve S, Candrilli SD, Dalal M. Digenio A, et al. Postgrad Med. 2014 Oct;126(6):49-59. doi: 10.3810/pgm.2014.10.2820. Postgrad Med. 2014. PMID: 25414934

3

Type 2 diabetes mellitus treatment patterns in U.S. nursing home residents.

Zarowitz B, Allen C, O'Shea T, Dalal MR, Haumschild M, DiGenio A. Zarowitz B, et al. Postgrad Med. 2015 Jun;127(5):429-37. doi: 10.1080/00325481.2015.1035621. Epub 2015 Apr 7. Postgrad Med. 2015. PMID: 25850712

4

Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.

Kovatchev B, Umpierrez G, DiGenio A, Zhou R, Inzucchi SE. Kovatchev B, et al. J Diabetes Sci Technol. 2015 Jun 15;9(6):1227-35. doi: 10.1177/1932296815587014. J Diabetes Sci Technol. 2015. PMID: 26078255 Free PMC article.

5

Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.

Umpierrez GE, O'Neal D, DiGenio A, Goldenberg R, Hernandez-Triana E, Lin J, Park CY, Renard E, Kovatchev B. Umpierrez GE, et al. Diabetes Obes Metab. 2017 Sep;19(9):1317-1321. doi: 10.1111/dom.12930. Epub 2017 May 5. Diabetes Obes Metab. 2017. PMID: 28256054 Clinical Trial.

6

Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets.

Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Dalal MR, et al. Diabetes Res Clin Pract. 2016 Nov;121:17-26. doi: 10.1016/j.diabres.2016.08.004. Epub 2016 Aug 24. Diabetes Res Clin Pract. 2016. PMID: 27616634

7

How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?

Inzucchi SE, Umpierrez G, DiGenio A, Zhou R, Kovatchev B. Inzucchi SE, et al. Diabetes Res Clin Pract. 2015 Apr;108(1):179-86. doi: 10.1016/j.diabres.2014.12.020. Epub 2015 Jan 21. Diabetes Res Clin Pract. 2015. PMID: 25661664 Corrected and republished. Clinical Trial.

8

Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus.

Munshi MN, Pandya N, Umpierrez GE, DiGenio A, Zhou R, Riddle MC. Munshi MN, et al. J Am Geriatr Soc. 2013 Apr;61(4):535-41. doi: 10.1111/jgs.12167. Epub 2013 Mar 21. J Am Geriatr Soc. 2013. PMID: 23581911 Clinical Trial.

9

Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences.

Shaefer C, Reid T, DiGenio A, Vlajnic A, Zhou R, Ameer B, Riddle M. Shaefer C, et al. Diabetes Metab Res Rev. 2015 Mar;31(3):269-79. doi: 10.1002/dmrr.2606. Epub 2014 Nov 18. Diabetes Metab Res Rev. 2015. PMID: 25255776 Clinical Trial.

10

Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1B_Rx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes.

Digenio A, Pham NC, Watts LM, Morgan ES, Jung SW, Baker BF, Geary RS, Bhanot S. Digenio A, et al. Diabetes Care. 2018 Apr;41(4):807-814. doi: 10.2337/dc17-2132. Epub 2018 Feb 9. Diabetes Care. 2018. PMID: 29439147 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results